Answers are grounded in this paper and cite their sources.
Background Non-small cell lung cancer (NSCLC), as the leading cause of cancer-related deaths globally, has consistently been the focus of clinical research aimed at optimizing its treatment strategies. For patients with locally advanced disease, pneumonectomy is an important radical treatment; however, the high postoperative recurrence rate and lack of precise individualized prognostic assessment tools pose significant clinical challenges. Therefore, identifying reliable prognostic biomarkers and constructing quantitative predictive models are crucial for guiding individualized postoperative management. Methods This study systematically evaluated the independent predictive value of lymph node metastasis staging (pN status) and lymphovascular invasion for recurrence-free survival (RFS) in NSCLC patients after pneumonectomy and constructed a nomogram. We retrospectively analyzed the clinicopathological data of 103 NSCLC patients who underwent pneumonectomy at a single center. Independent risk factors were identified using multivariate Cox proportional hazards regression models, and a nomogram was constructed based on the selected factors. The model’s discrimination and calibration were assessed through Bootstrap internal validation (600 resamplings). Results With a median follow-up of 17.73 months, the cohort recurrence rate was 56.31%. Multivariate analysis confirmed that pN0 versus pN2 (HR = 0.109, 95% CI: 0.017–0.705, P = 0.020) and lymphovascular invasion absent versus present (HR = 0.318, 95% CI: 0.142–0.713, P = 0.005) were independently associated with RFS.The nomogram model constructed based on these factors yielded a corrected concordance index (C-index) of 0.722 (95%CI: 0.655–0.790), and the calibration curve indicated good agreement between predicted and observed outcomes. Conclusion pN0 status is an independent protective factor against recurrence, and lymphovascular invasion is a key independent predictor of recurrence in NSCLC patients after pneumonectomy.The nomogram model constructed in this study provides a reliable individualized risk assessment tool for clinical practice, aiding in the identification of high-risk patients and optimization of postoperative monitoring and adjuvant treatment strategies. Future multicenter large-sample studies and integration of molecular biomarkers for external validation are needed to further enhance the clinical translational value of the model.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: